Cure
Overview
There's a growing need for clinicians who can provide mental health care. These nine tech companies are closing that gap through virtual care, digital platforms, and new approaches to delivering psychiatric services.
Demand for mental health care continues to outpace the supply of psychiatric providers, prompting a growing number of technology companies to try to close the gap by making care more accessible, expanding insurance coverage, and streamlining how clinicians deliver treatment. But as the sector has grown, so too have questions about whether these companies' business models can support the clinical realities of psychiatric care and whether technology can address the structural barriers that keep patients from getting care in the first place.
As a licensed therapist who was actively working for Cerebral, providing direct psychotherapy to subscribed clients during the time leading up to the company's DOJ settlement and $3.6+ million deferred prosecution agreement related to controlled substance prescribing and business practices, Colleen Canyon saw firsthand how tech-driven "solutions" operate behind the scenes. Canyon is a Licensed Clinical Social Worker (LCSW) and the founder of a private psychotherapy practice in Jersey City, NJ, specializing in helping high-functioning adults and couples navigate chronic anxiety, unresolved trauma, relationship conflicts, and deeply ingrained attachment patterns. “While my one-on-one therapeutic work with the clients was a quality experience, the clients' experiences with the company itself were not,” she shared.
Canyon said subscribers encountered rushed intakes, abrupt medication cutoffs that triggered withdrawal, complicated cancellation processes, and frequent clinician turnover. “In my opinion, the promise of tech companies closing the psychiatric care gap sounds revolutionary on paper, but in practice, venture capital and private equity models fundamentally clash with safe, ethical clinical care,” she said.
Those experiences shaped Canyon’s broader concerns about the way venture-backed mental health companies operate. While many startups market themselves as a way to "democratize mental health," she said the pressure to grow quickly, retain subscribers, and deliver returns to investors can come at the expense of clinical care. Cerebral, for example, was fined by the New York State Attorney General over its "burdensome cancellation process." The FTC also fined BetterHelp after alleging that the company had misled consumers about how it handled sensitive personal data.
For Canyon, the problem goes beyond individual company practices. She believes the financial structure of venture capital and private equity can put shareholders' interests at odds with clinicians' responsibility to their patients. “Real progress in digital mental health requires leveraging technology for accessibility without turning psychiatric care into an assembly line,” she added.
Canyon's concerns represent only one part of the access problem. Hashem Abdou, founder of Oasys Health, approaches the gap from the provider side. Oasys is an operating platform for growing behavioral-health group practices, combining clinical documentation, scheduling, insurance and payments, client communication, and telehealth in one system.
“One of the biggest gaps I see is between available clinical capacity and actually being able to access that capacity,” Abdou said. He explained how patients can get stuck trying to determine whether a provider accepts their insurance, whether they're taking new patients, completing intake paperwork, waiting for benefits to be verified, finding an appointment, or simply waiting for someone from a busy practice to return their call.
Abdou sees a need to reduce that friction. “Someone seeking mental-health or psychiatric care may already be dealing with depression, anxiety, overwhelm, or another condition that makes navigating a complicated system particularly difficult,” he explained. Administrative barriers that seem relatively small can ultimately become reasons someone doesn't access care at all.
Reducing that friction is also where Abdou sees one of the clearest opportunities for AI. “For me, the most immediate opportunity for AI is definitely not replacing clinical judgment,” he said. “It's reducing the repetitive administrative work surrounding it.” By taking on tasks such as documentation, intake, insurance verification, billing, and patient communication, he argues, technology can give clinicians more time to focus on care.
For Abdou, the test is whether those efficiencies actually translate into greater capacity. “I think the distinction is whether the technology changes the capacity of the system or simply changes the interface,” he said.
The companies profiled below are taking different approaches to that challenge, from helping patients find and pay for care to expanding clinical capacity and reducing the operational burden on the practices that provide it.
Talkiatry
Sector: Telepsychiatry / in-network virtual outpatient psychiatric and therapy care
HQ: New York, NY
Year Founded: 2019
Key Leaders: Robert Krayn and Dr. Georgia Gaveras co-founded Talkiatry in 2019 and serve as CEO and Chief Medical Officer, respectively.
Number of Employees: 501-1K
Stage / Funding Round: Private, Series D
Financial Snapshot: $210M Series D (Feb. 2026), bringing total funding to $400M+. The round was led by Perceptive Advisors, with participation from Sofina, Andreessen Horowitz, blisce/, and Left Lane Capital, alongside a debt facility from Banc of California.
Notable Investors: Perceptive Advisors, Sofina, Andreessen Horowitz (a16z), blisce/, Left Lane Capital, and Banc of California (debt financing).
Key Products / Pipeline: A fully virtual, nationwide outpatient psychiatric practice combining psychiatrists, licensed therapists, and proprietary technology to deliver in-network mental health care.
Recent Highlights: Between 2021 and 2024, the company's revenue grew 1,745%. Talkiatry is the largest private employer of psychiatrists, directly employing more than 800 full-time psychiatrists. It is now in-network with more than 100 insurers nationwide, covering more than 170 million lives, and has delivered 3 million patient visits to date.
Grow Therapy
Sector: Provider-focused mental health marketplace/technology platform
HQ: New York, NY
Year Founded: 2020
Key Leaders: Jake Cooper, CEO; Alan Ni, Co-Founder CTO; and Manoj Kanagaraj, MD, Co-Founder
Number of Employees: 201-500
Stage / Funding Round: Private, Series D
Financial Snapshot: $150 million Series D (Mar. 2026), bringing total funding to $328M. Bloomberg reported a $3 billion valuation and approximately $1 billion in revenue.
Notable Investors: TCV and Growth Equity at Goldman Sachs Alternatives (co-leads), BCI, Menlo Ventures, Sequoia Capital, SignalFire, and Transformation Capital.
Key Products / Pipeline: A platform that enables independent therapists and psychiatric providers to open in-network practices, offering in-person and online therapy and psychiatric care through a network of 26,000 providers.
Recent Highlights: More than 2 million people have used Grow's platform for therapy and medication management, with 7 million visits facilitated in 2025 alone, bringing the lifetime total to 10 million appointments. The company has expanded its insurer network from 75 to more than 125 health plan partners, and is extending into health systems through a partnership with Circle Medical.
Rula
Sector: Teletherapy / in-network mental healthcare marketplace
HQ: Santa Clara, CA
Year Founded: 2019 (originally launched as Path Mental Health/Path CCM)
Key Leaders: Gabe Diop, Co-Founder; Josh Bruno, CEO; Douglas Newton, MD, Chief Medical Officer; Alanna Nielson, COO
Number of Employees: 501-1K
Stage / Funding Round: Private, Series C
Financial Snapshot: $143 million Series C, bringing total funding to approximately $263 million. Sacra estimates Rula reached approximately $471 million in annualized gross revenue in 2024.
Notable Investors: Hedosophia, Sequoia Capital, Wing Venture Capital, Upfront Ventures, Tribe Capital, Four Rivers Group, and Meridian Street Capital.
Key Products / Pipeline: A network of over 21,000 providers across 100-plus specialties offering therapy and psychiatric services nationwide, including individual, couple, and family therapy in all 50 states and D.C. The platform also offers a payment guarantee model for providers.
Recent Highlights: In November 2024, Rula partnered with Amazon Health Services, allowing Amazon users to find and book Rula providers directly through Amazon.com, with typical session copays around $15. In November 2025, Rula partnered with Sidecar Health to expand access to virtual therapy and psychiatry for Sidecar members.
Headway
Sector: Insurance-based mental healthcare marketplace/EHR platform
HQ: New York, NY
Year Founded: 2019
Key Leaders: Andrew Adams (CEO) founded the company alongside Dan Ross, Jake Sussman, and Kevin Chan.
Number of Employees: 501-1K
Stage / Funding Round: Private, Series D
Financial Snapshot: $100M Series D (July 2024), bringing the company to a $2.3B valuation approximately $325M in total funding.
Notable Investors: Spark Capital, Thrive Capital, Accel, Andreessen Horowitz (a16z), and Forerunner Ventures, Health Care Service Corporation (HCSC)
Key Products / Pipeline: A platform that streamlines credentialing, onboarding, clinical training, scheduling, and billing, enabling clinicians to accept insurance. In 2025, its network included more than 65,000 providers across all 50 states and works with over 100 insurance plans, including Medicare Advantage and Medicaid.
Recent Highlights: In September 2025, Headway announced an expansion of its free, AI-assisted, insurance-native Electronic Health Record (EHR) system for mental health providers. Headway also became the first launch partner of the National Quality Forum's Aligned Innovation initiative.
Osmind
Sector: Psychiatric practice-management technology and EHR platform (ketamine, Spravato, TMS, and other interventional treatments)
HQ: San Francisco, CA
Year Founded: 2020
Key Leaders: Lucia Huang and Jimmy Qian co-founded Osmind in 2020 and continue to lead the firm as CEO and President.
Number of Employees: 51-200
Stage / Funding Round: Private, Series B
Financial Snapshot: $40M Series B, bringing total funding to $57M since founding. The round was led by DFJ Growth.
Notable Investors: DFJ Growth, Susa Ventures, General Catalyst, Future Ventures, Tiger Global, Pear VC, and Y Combinator.
Key Products / Pipeline: A purpose-built EHR, software solutions, and managed services serving 1,000 independent practices with support for ketamine therapy, SPRAVATO®, and transcranial magnetic stimulation (TMS).
Recent Highlights: In May 2025, Osmind bolstered its leadership team, including hiring Adrian Vera as CTO, to build solutions that help psychiatric practices manage administrative complexity amid the growth of interventional treatments such as Spravato, TMS, and ketamine.
Blossom Health
Sector: AI-native telepsychiatry ("AI operating system" for psychiatry)
HQ: New York, NY
Year Founded: 2024
Key Leaders: Founded and led by John Zhao (formerly VP of Product and General Manager at Athelas and scale leader at EverQuote).
Number of Employees: 11-50
Stage / Funding Round: Private, Series A (plus seed)
Financial Snapshot: $20 million raised across its seed and Series A rounds. The company initially emerged from stealth in October 2025 with $18.4 million in funding.
Notable Investors: Headline (lead), Village Global, Correlation Ventures, TA Ventures, Operator Partners, plus angel investors from Flatiron Health, Sword Health, Zip, Blank Street, Elemy, Fay, Assured, Birches Health, Bridge, and Enzo Health.
Key Products / Pipeline: An AI "copilot" and operating system for psychiatry that augments clinicians by handling documentation, workflow, and support tasks across the patient journey. Its agentic AI also streamlines medical decision-making, billing, treatment plan personalization, and medication selection.
Recent Highlights: Hundreds of clinicians already use Blossom to treat more than 10,000 patients across multiple states. Its clinician tools save 30+ minutes per patient visit (10+ hours weekly), while most patients are seen within 48 hours, often the same day, at average copays around $22.
Radial
Sector: Interventional psychiatry clinic network (TMS, Spravato/esketamine, neuromodulation)
HQ: New York, NY
Year Founded: 2023
Key Leaders: John Capecelatro, CEO & Co-Founder; Elliot Cohen, Executive Chairman and Co-founder; Owen Scott Muir, MD, Chief Scientific Officer and Co-Founder; Carlene MacMillan, MD, Chief Product Officer and Co-Founder; Jonathan Murray, Chief Commercial Officer
Number of Employees: 11-50
Stage / Funding Round: Private, Series A
Financial Snapshot: Launched with $50M Series A venture funding in December 2025.
Notable Investors: General Catalyst (lead), Solari Capital, JSL Health Capital, Founder Collective, BoxGroup, Scrub Capital, SV Angel, and Diede van Lamoen.
Key Products / Pipeline: Advanced interventional psychiatry treatments including TMS, Spravato (esketamine), SAINT TMS, PRISM Neurofeedback, and GammaCore vagus nerve stimulation for depression, PTSD, OCD, anxiety, ADHD, bipolar disorder, and personality disorders. Treatments are delivered through a national clinic network accepting Medicare, Tricare, VA CCN, Aetna, Cigna, United, and many Blue plans.
Recent Highlights: Radial currently operates seven clinics across six states and reports depression remission rates reaching as high as 78% in some studies its team has co-authored. The company plans to expand nationally in 2026.
Salma Health
Sector: Integrated brain health / interventional psychiatry centers (diagnostics, TMS, Spravato, SAINT)
HQ: San Mateo, CA
Year Founded: 2025
Key Leaders: Founding team includes Alaa Halawa, Ayman AlAbdallah, Brandon Bentzley, Emily Phillips-Bru and Zeena Ojjeh
Number of Employees: 51-200
Stage / Funding Round: Private, Series A
Financial Snapshot: Emerged from stealth with $80 million in Series A funding in February 2026.
Notable Investors: Mubadala Capital and ARCH Venture Partners (co-leads), Lingotto Horizon, and Averin Capital.
Key Products / Pipeline: Personalized, science-backed treatments for depression, anxiety, PTSD, OCD, brain injuries, headaches, memory/dementia, and cognitive challenges, combining advanced diagnostics, neuromodulation therapies (TMS, Esketamine, SAINT®), medication management, and lifestyle support.
Recent Highlights: Salma Health is building centers of excellence to bring diagnostics, rapid-acting treatments, and coordinated care under one roof, targeting psychiatric, neurological, and neuropsychiatric conditions. It currently operates locations in Orange County, San Diego, Fremont, Berkeley, and the Bay Area, with plans to expand into Los Angeles.
Brave Health
Sector: Virtual behavioral health for Medicaid populations (telehealth therapy, psychiatry, medication-assisted treatment, and substance use disorder care)
HQ: Miami, FL
Year Founded: 2017
Key Leaders: Anna Lindow co-foundedthe company alongside Jake Schwartz; Sarah Tilton, CEO
Number of Employees: 201-500
Stage / Funding Round: Private, Series C
Financial Snapshot: $40M Series C (Oct. 2022), bringing total funding to $60M. The round was led by Town Hall Ventures.
Notable Investors: Town Hall Ventures (lead), Union Square Ventures, City Light Capital, and Able Partners.
Key Products / Pipeline: Telehealth-enabled counseling, therapy, psychiatry, case management, and medication-assisted treatment (MAT) for mental health and substance use disorders, delivered primarily to Medicaid populations, with some commercial and Medicare plan contracts as well.
Recent Highlights: As of the 2022 raise, Brave Health served over 65 million covered lives across more than 200 health plan contracts in 18 states. The company entered its first value-based care arrangement with Molina Healthcare of Texas, later adding a value-based contract with Centene's Sunshine Health, bringing potential Medicaid members covered under value-based arrangements to more than one million. It also partnered with The Doula Network to provide mental health support to expectant Medicaid mothers, and with MedArrive to enable real-time referrals from home-based care visits into Brave Health's behavioral health services.
